A new vaccine is changing how doctors treat certain skin cancer patients, according to doctors in the ArkLaTex.
An Auckland woman who has spent months campaigning for cancer drug funding says the Petitions Select Committee’s response to ...
Nevertheless, in the past year, Merck (MRK) delivered an impressive 73% return to investors, outpacing the S&P 500. The peak ...
Amid rising cancer burden in India, the mRNA custom-made cancer vaccine for melanoma has intriguing potential. ​While typical ...
President Donald Trump’s announcement this week of White House aide Heidi Overton as his pick to lead the FDA gave the pharma ...
The vaccine, when combined with the immunotherapy drug Keytruda, reduced skin cancer recurrence and the results were ...
Moderna has now swung violently in both directions for three straight sessions on the same unchanged clinical news, and the ...
Early results from final-stage trial of individualised melanoma jab offer hope of more tailor-made cancer treatments ...
Cancer patients may be receiving higher doses and longer courses of expensive drugs than they need. Also, we see Moderna’s ...
Merck and Moderna’s personalised mRNA cancer vaccine shows promising melanoma results, potentially changing how doctors ...
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a ​new avenue of ...
MEXC, a pioneer in 0-fee digital asset trading, has listed the MRNAON/USDT trading pair on Spot, giving users a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results